MiR-101 is involved in human breast carcinogenesis by targeting Stathmin1.
about
Noncoding RNA in oncogenesis: a new era of identifying key playersStathmin-dependent molecular targeting therapy for malignant tumor: the latest 5 years' discoveries and developmentsMicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics.Down-regulated microRNA-101 in bladder transitional cell carcinoma is associated with poor prognosisHsa-microRNA-101 suppresses migration and invasion by targeting Rac1 in thyroid cancer cells.Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patientsmiR‑542‑3p overexpression is associated with enhanced osteosarcoma cell proliferation and migration ability by targeting Van Gogh‑like 2.MiR-26a inhibits proliferation and migration of breast cancer through repression of MCL-1MiR-101 sensitizes human nasopharyngeal carcinoma cells to radiation by targeting stathmin 1.P18/Stathmin1 is regulated by miR-31 in ovarian cancer in response to taxanemiR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells.Cyclooxygenase-2, a Potential Therapeutic Target, Is Regulated by miR-101 in Esophageal Squamous Cell Carcinoma.MiR-101 inhibits cell growth and tumorigenesis of Helicobacter pylori related gastric cancer by repression of SOCS2.MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer.MicroRNA-101 targets von Hippel-Lindau tumor suppressor (VHL) to induce HIF1α mediated apoptosis and cell cycle arrest in normoxia condition.MiRNA-101 inhibits breast cancer growth and metastasis by targeting CX chemokine receptor 7.WBSMDA: Within and Between Score for MiRNA-Disease Association prediction.mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPK.MicroRNA-101 regulated transcriptional modulator SUB1 plays a role in prostate cancer.Genetic variations in the flanking regions of miR-101-2 are associated with increased risk of breast cancer.miR-101 inhibits cell proliferation by targeting Rac1 in papillary thyroid carcinoma.microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer.Knockdown of STMN1 enhances osteosarcoma cell chemosensitivity through inhibition of autophagyEffect of microRNA-101 on proliferation and apoptosis of human osteosarcoma cells by targeting mTOR.Regulation of epithelial-mesenchymal transition through microRNAs: clinical and biological significance of microRNAs in breast cancer.Downregulation of miR-101-3p by hepatitis B virus promotes proliferation and migration of hepatocellular carcinoma cells by targeting Rab5a.Functional analysis of miR-101-3p and Rap1b involved in hepatitis B virus-related hepatocellular carcinoma pathogenesis.MiR-98 is involved in rat embryo implantation by targeting Bcl-xl.NARRMDA: negative-aware and rating-based recommendation algorithm for miRNA-disease association prediction.miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression.
P2860
Q26823718-02EF3B7C-C2C0-4158-BBB7-FE42A929350CQ28079927-87560BAB-2615-4B02-84A9-3B4D036CC0D8Q28266383-7EA59986-2E96-4089-9976-55531AFACF35Q33602610-22E086D2-70BD-48CA-A9A7-4B2E7F60AFA7Q33686261-099D1C0A-9258-4E85-98F2-B39578D3C779Q34141872-44F486DB-C8BA-42C2-B70F-E7A680554BAFQ34654554-C39C8D36-9D3A-4ED6-84CF-23020B2D521DQ34673626-2802B6E3-38A8-489B-BC6D-A474F6339DAAQ34764211-1A71A049-820F-473C-9BFC-075FCCC8D8F8Q35201698-95F6D3B4-67B4-424A-9EE4-64BD77D6FFF5Q35376227-3EFEF76D-B5F7-42F3-81DB-A392BAEB9314Q35557027-60E8A43C-864C-4355-B6D9-6C4BB774CA52Q35838020-97D742F4-3CEE-495F-97E6-B25CCC177136Q36213718-8DF4516A-0BB8-4EEB-B952-EE946342972AQ36299580-6E47DB57-B5DE-4E8A-BE4B-1F3BCEA9666DQ36542711-0AA31E42-9FAF-4EBA-B08F-6580F9EB4686Q36544430-365F3380-115C-4AE7-9D6D-02CA9F1DC874Q36583369-D37ACF89-0097-45F1-80B0-FCF462EA4045Q37376505-5B28EDBE-B4B8-4047-A7B4-56761A8E366FQ37478622-16581C8D-919F-41FE-B936-9503F154B406Q37514266-49D4E5DD-D344-4D79-921D-A3F46BE13C1FQ37565598-BF0AB91A-038C-4A2F-A644-CC006A8FBA19Q38336073-831BBAEB-BA5C-4E04-91E6-0B855C973D54Q38772091-22225FA9-BF31-4831-897C-4E6177BFB8C6Q38931801-A45D66BE-6D33-44CF-9E7E-B9B84925C739Q38958559-098A9B0C-D122-4E4F-B787-1B2958ED19B8Q38999469-C89405BF-0248-4184-A504-AA11442B87D9Q39008544-C074D458-B400-4C2B-932A-66AA49F317D1Q46121766-2681632A-66AA-4B83-A548-57CB4BF6942CQ47426585-B7B4D3DD-0D24-45C7-8C6C-A2F8596DB293Q47660322-8E8C773E-EB2D-4F5E-A2B1-AA2ACA8BA572
P2860
MiR-101 is involved in human breast carcinogenesis by targeting Stathmin1.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
MiR-101 is involved in human breast carcinogenesis by targeting Stathmin1.
@ast
MiR-101 is involved in human breast carcinogenesis by targeting Stathmin1.
@en
MiR-101 is involved in human breast carcinogenesis by targeting Stathmin1.
@nl
type
label
MiR-101 is involved in human breast carcinogenesis by targeting Stathmin1.
@ast
MiR-101 is involved in human breast carcinogenesis by targeting Stathmin1.
@en
MiR-101 is involved in human breast carcinogenesis by targeting Stathmin1.
@nl
prefLabel
MiR-101 is involved in human breast carcinogenesis by targeting Stathmin1.
@ast
MiR-101 is involved in human breast carcinogenesis by targeting Stathmin1.
@en
MiR-101 is involved in human breast carcinogenesis by targeting Stathmin1.
@nl
P2093
P2860
P1433
P1476
MiR-101 is involved in human breast carcinogenesis by targeting Stathmin1.
@en
P2093
Chan Juan Hao
Fei-Feng Li
Hong-Bin Wang
Hong-Fei Xia
Xiao-Chen Han
P2860
P304
P356
10.1371/JOURNAL.PONE.0046173
P407
P577
2012-10-11T00:00:00Z